medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2017, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2017; 15 (2)

Chromoblastomycosis. Case Report with Atypical Localization

Ferrá TTM, Florat GD, Flores SSL, Coox YG

Language: Spanish
References: 23
Page: 81-83
PDF size: 143.36 Kb.


ABSTRACT

Chromoblastomycosis is a chronic subcutaneous mycosis deep and long chronic course, caused by a group of fungal dematiaceous particularly affecting the lower limbs. The disease occurs in tropical and subtropical areas. Fungal penetration occurs through wounds or through skin trauma in contact with contaminated soil by inhabited saprophytic fungal species, usually affecting agricultural workers. This article describes a case of chromoblastomycosis by Phialophora verrucosa in a patient with a five years history of an injury in an atypical location.


REFERENCES

  1. Avelar-Pires C, Simoes-Quaresma J, Moraes-de Macedo G et al., Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region, Archiv Med Res 2013; 44(4): 302-6.

  2. Sugiyama Y, Suzuki Y, Sugaya K et al., Chromoblastomycosis caused by Fonsecae a monophora, MedMycol J 2011; 52(3): 255-60.

  3. Vargas-Arzola J, Reyes-Velasco L, Segura-Salvador A y Hernández- Hernández F, Cromoblastomicosis por Phialophora verrucosa. Reporte de un caso, Dermatol Rev Mex 2012; 56(2): 141-4.

  4. González Escudero M, Morales Piñeiro S y Morales Morera T, Cromomicosis. Presentación de un paciente, Medicentro Electrónica 2013; 17(3): 133-7.

  5. Arenas R, Micología médica ilustrada, 5a ed., McGraw-Hill, México, 2014, pp. 137-259.

  6. Andrade Pineda RE y Marcano-Lozada MJ, La microbiología actualizada en enfermedades emergentes y reemergentes, parte II, Vitae Academia Biomédica Digital 2005; 24: 1-10.

  7. Sousa MG, Bou Ghosn EE, Ciciro Nascimento R et al., Monocytederived dendritic cells from patients with severe forms of chromoblastomycosis induce cd4 + t cell activation in vitro, Clin Exp Immunol 2009; 156(1): 117-25.

  8. Richard-Yegres N y Yegres F, Cromomicosis: una endemia rural en la región noroccidental en Venezuela, Rev Cubana Med Trop 2009; 61(3): 209-12.

  9. Lu S, Lu C, Zhang J et al., Chromoblastomycosis in mainland China: a systematic review on clinical characteristics, Mycopathologia 2013; 175(5-6): 489-95.

  10. Sánchez Saldaña L, Galarza Manyari C y Matos Sánchez R, Infecciones micóticas subcutáneas, Dermatol Peruana 2009; 19(4): 362-87.

  11. Hay RJ, Enfermedades micóticas profundas. En Goldsmith LA, Katz S, Gilchrest BA et al., Dermatología en medicina general, 8a ed., Médica Panamericana, Madrid, 2014, pp. 2312-28.

  12. Bonifaz A, Micología médica básica, 4a ed., McGraw-Hill, México, 2012, pp. 231-46.

  13. Culp L, Al-Dabagh A y Feldman S, Treating rare fungal infections: chromoblastomycosis, Dermatol 2013; 21(7): 1-8.

  14. Negroni R, Arechavala A, Maiolo E et al., Clinical cases in medical mycology. Case no. 31, Rev Iberoam Micol 2008; 25(1): 62-4.

  15. Vargas Arzola J, Reyes Velasco L, Segura Salvador A y Hernández Hernández F, Cromoblastomicosis por Phialophora verrucosa. Reporte de un caso, Dermatol Rev Mex 2012; 56(2): 141-4.

  16. Marinho Correia RT, Valente N, Criado PR y Da Costa Martins JE, Cromoblastomicose: relato de 27 casos e revisão da literatura, An Bras Dermatol 2010; 85(4): 448-54.

  17. Romero Navarrete M et al., Cromoblastomicosis en México: revisión de 603 casos en siete décadas, dcmq 2014; 12(2): 89-90.

  18. Badali H, Fernández González M, Mousavi B et al., Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba, Mycopathologia 2013; 175(5-6): 439-44.

  19. Calvo E, Pastor F, Salas J et al., Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii, Antimicrob Chemother 2012; 67(3): 666-70.

  20. Siqueira IM, Ribeiro AM, Nobrega YK et al., dna-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by Fonsecaea pedrosoi, Mycopathologia 2013; 175(5-6): 463-75.

  21. Torres-Guerrero E, Isa-Isa R, Isa M y Arenas M, Chromoblastomycosis, Clin Dermatol 2012; 30(4): 403-8.

  22. Queiroz-Telles F y Santos DW, Challenges in the therapy of chromoblastomycosis, Mycopathologia 2013; 175(5-6): 477-88.

  23. Tamura K, Matsuyama T, Yahagi E et al., A case of chromomycosis treated by surgical therapy combined with preceded oral administration of terbinafine to reduce the size of the lesion, Tokai J Exp Clin Med 2012; 37(1): 6-10.




2020     |     www.medigraphic.com